Bioanalytical Scientific Guidance from Discovery to Preclinical to Phase IV

 

From discovery to preclinical to Phase IV, Altasciences’ bioanalytical team of over 260 scientific experts specialized in bioanalysis, ligand binding assays (LBA), mass spectrometry, immunology, biomarkers, flow cytometry, and PCR, operates in three strategic locations in proximity to our preclinical and clinical sites. We aim to provide top quality data for TK, PK, and PD determinations to support your preclinical and clinical studies.   

At Altasciences, One Laboratory Sciences moves in unison for the success and acceleration of drug development.

Let’s schedule time to discuss your bioanalytical needs.


You may also be interested in the following:

• Podcast — Three Laboratories - One Vision, with Dr. Lynne Le Sauteur
• Webinar — Managing Challenging Bioanalysis for PK/PD Assessments for Phase I Biologics
• Video — Take a Look Inside our PCR Lab
• Press Release — Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.